financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Hold Opinion On Shares Of Alimentation Couche-tard Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold Opinion On Shares Of Alimentation Couche-tard Inc.
Mar 22, 2024 6:15 AM

08:35 AM EDT, 03/22/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our 12-month target by CAD2 to CAD80, 19x our FY 25 (Apr.) EPS and a premium to ATD's long-term mean of 17x. We cut our FY 24 EPS by $0.08 to $3.03 (CAD4.09) and FY 25's by $0.13 to $3.12 (CAD4.21). F3Q (Jan-Q) adj-EPS of $0.65 (-12% Y/Y) missed by $0.19. Revenue of $19,622M missed consensus by 6%. Same-store (SS) merchandise sales fell in all regions, driven by macro headwinds and softness in the cigarette category. SS fuel volumes were also weak, particularly diesel demand, which likely drove less in-store traffic. Fuel margins fell 8% Y/Y in the U.S., which is a bit concerning since convenience store operators have been leaning in on stronger fuel margins over the past few years to offset other cost pressures. The positive in this quarter was operating expense control, as normalized operating expenses fell 1.6% Y/Y, driven by labor efficiencies in the stores. ATD closed on the $3.8B TotalEnergies acquisition in January (+2,175 sites across Europe) and expects $187M of synergies over five years.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Shares Of Johnson & Johnson To Buy From Hold
Research Alert: CFRA Raises Opinion On Shares Of Johnson & Johnson To Buy From Hold
Oct 14, 2025
11:05 AM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Q3 earnings and the announcement of the separation of Orthopedics, we raise our target to $220 from $166. This is based on 19.2x our 2026 EPS estimate and is...
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of The Goldman Sachs Group
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of The Goldman Sachs Group
Oct 14, 2025
02:40 PM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $850, applying a forward P/E of 15.6x our 2026 earnings estimate compared to the five-year historical average for normalized EPS at 15.5x. We...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Blackrock, Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Blackrock, Inc.
Oct 14, 2025
12:30 AM EDT, 10/15/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $95, to $1,340, valuing BLK shares at 22x our newly initiated 2027 adjusted EPS estimate of $60.50, and at 25x our 2026 EPS...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Jpmorgan Chase & Co.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Jpmorgan Chase & Co.
Oct 14, 2025
12:20 PM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $340, applying a forward P/E of 15.5x, near the three-year historical average at 15.0x on normalized earnings. We keep our EPS estimates at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved